(0.14%) 5 107.18 points
(0.28%) 38 347 points
(-0.04%) 15 922 points
(-0.38%) $83.53
(2.24%) $1.966
(-0.28%) $2 340.70
(-0.16%) $27.49
(2.73%) $947.30
(0.03%) $0.935
(-0.06%) $11.02
(-0.20%) $0.799
(1.90%) $93.62
-0.47% £ 0.513
Live Chart Being Loaded With Signals
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally...
Stats | |
---|---|
Volumen de hoy | 2.40M |
Volumen promedio | 22.53M |
Capitalización de mercado | 16.37M |
EPS | £0 ( 2023-09-11 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -0.510 |
ATR14 | £0.0140 (2.72%) |
Volumen Correlación
Yourgene Health PLC Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Yourgene Health PLC Correlación - Moneda/Commodity
Yourgene Health PLC Finanzas
Annual | 2022 |
Ingresos: | £37.56M |
Beneficio Bruto: | £21.37M (56.88 %) |
EPS: | £-0.00260 |
FY | 2022 |
Ingresos: | £37.56M |
Beneficio Bruto: | £21.37M (56.88 %) |
EPS: | £-0.00260 |
FY | 2021 |
Ingresos: | £18.29M |
Beneficio Bruto: | £11.38M (62.20 %) |
EPS: | £-0.0307 |
FY | 2020 |
Ingresos: | £16.61M |
Beneficio Bruto: | £10.22M (61.55 %) |
EPS: | £-0.00400 |
Financial Reports:
No articles found.
Yourgene Health PLC
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products, as well as extraction for DNA, RNA/miRNA, and nucleons; quantification; genotyping; gene expression; methylation; and microarray services for clinical research organizations. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico